FDA Limits Use of Johnson & Johnson's COVID-19 Vaccine to Certain Individuals - All You Should Know

The FDA said it was limiting the use of Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine for adults due to the risk of a rare blood clotting syndrome.

The J&J shot can be administered in cases where authorized or approved COVID-19 vaccines are not accessible, or if an individual is less keen on using the other two shots, the FDA said.